STOCKHOLM--(BUSINESS WIRE)--Regulatory News: In December 2014 BioGaia (STO:BIOGB) reported its decision to invest SEK 12 million in MetaboGen AB, Gothenburg, Sweden. The investment should be made over a two year period. The first investment of SEK 4 million took place in December 2014 and as MetaboGen has reached the agreed milestones the second investment of SEK 4 million was made today. BioGaia thereafter owns 27% of the share capital of MetaboGen, and if further milestones will be reached, t